Cargando…
Glucagon Receptor Antagonism Ameliorates Progression of Heart Failure
Mice were treated with a fully human monoclonal glucagon receptor antagonistic antibody REMD2.59 following myocardial infarction or pressure overload. REMD2.59 treatment blunted cardiac hypertrophy and fibrotic remodeling, and attenuated contractile dysfunction at 4 weeks after myocardial infarction...
Autores principales: | Gao, Chen, Ren, Shuxun Vincent, Yu, Junyi, Baal, Ulysis, Thai, Dung, Lu, John, Zeng, Chunyu, Yan, Hai, Wang, Yibin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6488764/ https://www.ncbi.nlm.nih.gov/pubmed/31061918 http://dx.doi.org/10.1016/j.jacbts.2018.11.001 |
Ejemplares similares
-
Administration of a TLR9 Inhibitor Attenuates the Development and Progression of Heart Failure in Mice
por: Ueda, Hiromichi, et al.
Publicado: (2019) -
Resolution of Heart Failure Inflammation
por: Bäck, Magnus
Publicado: (2022) -
Activation of glucagon‐like peptide‐1 receptors and skilled reach foraging
por: Vestlund, Jesper, et al.
Publicado: (2020) -
Location-specific and Kinase-Independent GRK5 Function in Heart
por: Wang, Yifan F., et al.
Publicado: (2022) -
Western Diet-Fed, Aortic-Banded Ossabaw Swine: A Preclinical Model of Cardio-Metabolic Heart Failure
por: Olver, T. Dylan, et al.
Publicado: (2019)